🇺🇸 Mifepristone tablets in United States

3,295 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 3,295

Most-reported reactions

1. Abortion Incomplete — 893 reports (27.1%)
2. Haemorrhage — 866 reports (26.28%)
3. Pregnancy — 388 reports (11.78%)
4. Anaemia — 324 reports (9.83%)
5. Pain — 177 reports (5.37%)
6. Menorrhagia — 160 reports (4.86%)
7. Muscle Spasms — 153 reports (4.64%)
8. Pyrexia — 117 reports (3.55%)
9. Dizziness — 112 reports (3.4%)
10. Abdominal Pain — 105 reports (3.19%)

Source database →

Frequently asked questions

Is Mifepristone tablets approved in United States?

Mifepristone tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Mifepristone tablets in United States?

China Resources Zizhu Pharmaceutical Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.